NOVARTIS AG - Ordinary Shares (NVS)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NVS on NYSE
CUSIP
66987V109
Type / Class
Equity / Ordinary Shares
Shares outstanding
2.18B
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
133M
Holdings value
$17.1B
% of all portfolios
0.031%
Grand Portfolio weight change
+0%
Number of holders
1342
Number of buys
559
Number of sells
-532
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NOVARTIS AG - Ordinary Shares (NVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 6.4% $15.2B 140M UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sep 30, 2024

Institutional Holders of NOVARTIS AG - Ordinary Shares (NVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 133M $17.1B +$52.9M $128.24 1,342
2025 Q2 133M $16.1B -$491M $121.01 1,364
2025 Q1 138M $15.3B +$873M $111.48 1,335
2024 Q4 130M $12.7B -$228M $97.31 1,322
2024 Q3 132M $15.2B -$630M $115.02 1,298
2024 Q2 138M $14.7B -$144M $106.46 1,296
2024 Q1 140M $13.6B -$127M $96.73 1,236
2023 Q4 343K $34.6M -$6.16M $100.97 15
2023 Q3 141M $14.3B -$4.45M $101.86 1,198
2023 Q2 148M $14.9B -$2.34B $100.91 1,176
2023 Q1 162M $14.9B -$599M $92.00 1,150
2022 Q4 171M $15.5B -$839M $90.72 1,159
2022 Q3 179M $13.6B -$1.53B $76.01 1,063
2022 Q2 199M $16.8B -$490M $84.53 1,118
2022 Q1 206M $18.1B -$258M $87.75 1,112
2021 Q4 210M $18.4B -$804M $87.47 1,128
2021 Q3 219M $17.9B +$334M $81.78 1,066
2021 Q2 217M $19.8B -$95.5M $91.24 1,105
2021 Q1 218M $18.6B -$805M $85.48 1,125
2020 Q4 228M $21.5B +$236M $94.43 1,163
2020 Q3 226M $19.7B -$1B $86.96 1,103
2020 Q2 237M $20.7B -$813M $87.34 1,116
2020 Q1 246M $20.3B -$536M $82.45 1,116
2019 Q4 257M $24.4B +$1.32B $94.69 1,155
2019 Q3 232M $20.1B -$998M $86.90 1,076
2019 Q2 255M $23.2B -$1.28B $91.31 1,079
2019 Q1 265M $25.4B -$71.8M $96.14 1,115
2018 Q4 273M $23.4B +$1.01B $85.81 1,074
2018 Q3 259M $22.3B +$464M $86.16 1,007
2018 Q2 254M $19.2B +$311M $75.54 972
2018 Q1 256M $20.7B +$329M $80.85 1,000
2017 Q4 250M $21B -$565M $83.96 992
2017 Q3 258M $22.1B -$116M $85.85 926
2017 Q2 259M $21.6B -$436M $83.47 908
2017 Q1 253M $18.8B +$1.1B $74.27 897
2016 Q4 237M $17.2B +$772M $72.84 893
2016 Q3 225M $17.7B -$14M $78.96 863
2016 Q2 223M $18.4B -$253M $82.51 867
2016 Q1 222M $16.1B +$157M $72.44 859
2015 Q4 233M $20B +$58.1M $86.04 921
2015 Q3 234M $21.5B +$272M $91.92 915
2015 Q2 231M $22.7B +$105M $98.34 935
2015 Q1 234M $23.1B -$41.9M $98.61 929
2014 Q4 234M $21.7B +$109M $92.66 901
2014 Q3 230M $21.7B -$347M $94.13 862
2014 Q2 236M $21.3B -$159M $90.53 835
2014 Q1 237M $20.2B -$335M $85.02 824